Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endometrial carcinoma.

W K Huh1, J M Straughn, F J Kelly

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, 619 19th Street South, OHB Room 538, Birmingham, AL 35249, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human exposure to diesel exhaust induces CYP1A1 expression and AhR activation without a coordinated antioxidant response.

Particle and fibre toxicology·2023
Same author

Associations between air pollutants and blood pressure in an ethnically diverse cohort of adolescents in London, England.

PloS one·2023
Same author

Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey.

Gynecologic oncology reports·2021
Same author

Characterization of the public transit air microbiome and resistome reveals geographical specificity.

Microbiome·2021
Same author

Oxidative stress in air pollution research.

Free radical biology & medicine·2020
Same author

Atmospheric microplastic deposition in an urban environment and an evaluation of transport.

Environment international·2020
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Lymphadenectomy is recommended for all endometrial cancer patients. This procedure is safe, provides prognostic information, and aids in developing effective, cost-efficient treatment strategies.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology

Background:

  • Endometrial cancer is a frequent malignancy of the female reproductive system.
  • Most patients are diagnosed with early-stage disease, typically treated with hysterectomy.
  • The role of lymphadenectomy in endometrial cancer management remains a subject of debate.

Purpose of the Study:

  • To evaluate the safety and therapeutic potential of lymphadenectomy in endometrial cancer.
  • To highlight the prognostic value of lymphadenectomy in treatment planning.

Main Methods:

  • Review of current scientific literature supporting lymphadenectomy in endometrial cancer.
  • Analysis of safety and efficacy data for pelvic and para-aortic lymphadenectomy.

Main Results:

Related Experiment Videos

  • Growing evidence supports lymphadenectomy for all endometrial cancer patients.
  • Pelvic and para-aortic lymphadenectomy, when performed by experienced surgeons, is safe.
  • The procedure yields crucial prognostic information.

Conclusions:

  • Lymphadenectomy is a safe and potentially therapeutic intervention for endometrial cancer.
  • Prognostic data from lymphadenectomy facilitates personalized and cost-effective treatment strategies.
  • Routine lymphadenectomy can improve patient management and outcomes in endometrial cancer.